EDGAR Filing Documents for 0000885590-12-000054

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000885590-12-000054

Filing Date

2012-08-03

Accepted

2012-08-03 14:10:04

Documents

Period of Report

2012-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	valeantq22012-rollforward.htm	10-Q	2427992
2	EXHIBIT 4.1	exhibit41convertnotes1stsu.htm	EX-4.1	39130
3	EXHIBIT 4.2	exhibit42septindent5thsupi.htm	EX-4.2	101895
4	EXHIBIT 4.3	exhibit4_3novindent4thsupi.htm	EX-4.3	101923
5	EXHIBIT 4.4	exhibit44febindent3rdsupin.htm	EX-4.4	99714
6	EXHIBIT 4.5	exhibit45marchindent3rdsup.htm	EX-4.5	102025
7	EXHIBIT 4.6	exhibit46.htm	EX-4.6	38668
8	EXHIBIT 4.7	exhibit47.htm	EX-4.7	38050
9	EXHIBIT 4.8	exhibit48.htm	EX-4.8	38075
10	EXHIBIT 4.9	exhibit49.htm	EX-4.9	38386
11	EXHIBIT 10.2	exhibit102.htm	EX-10.2	260445
12	EXHIBIT 31.1	exhibit311.htm	EX-31.1	14301
13	EXHIBIT 31.2	exhibit312.htm	EX-31.2	14255
14	EXHIBIT 32.1	exhibit321.htm	EX-32.1	8545
15	EXHIBIT 32.2	exhibit322.htm	EX-32.2	8526
	Complete submission text file	0000885590-12-000054.txt		23887400

Data Files

Seq	Description	Document	Type	Size
16	EX-101.INS	vrx-20120630.xml	EX-101.INS	3571828
17	EX-101.SCH	vrx-20120630.xsd	EX-101.SCH	209697
18	EX-101.CAL	vrx-20120630_cal.xml	EX-101.CAL	151398
19	EX-101.DEF	vrx-20120630_def.xml	EX-101.DEF	1238600
20	EX-101.LAB	vrx-20120630_lab.xml	EX-101.LAB	3040254
21	EX-101.PRE	vrx-20120630_pre.xml	EX-101.PRE	1570510

Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9

Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792

Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)